Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia

Abstrakt

Study included patients with rheumatoid arthritis of moderate activity the main objective of the study was to proof that after reaching low disease activity it is possible to taper the dose without big risk of flare

Klíčová slova

• rheumatoid arthritis
• etanercept
• low disease aktivity